| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-05-17 01:00:20 UTC |
|---|
| Update Date | 2021-09-14 15:18:57 UTC |
|---|
| HMDB ID | HMDB0060406 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 5'-Deoxy-5-fluorouridine |
|---|
| Description | 5'-Deoxy-5-fluorouridine, also known as 5'-DFUR or 5-fluoro-5'-deoxyuridine, belongs to the class of organic compounds known as 5'-deoxyribonucleosides. These are nucleosides in which the oxygen atom at the 5'position of the ribose moiety has been replaced by another atom. The nucleobases here are limited to purine, pyrimidine, and pyridine derivatives. 5'-Deoxy-5-fluorouridine is an extremely weak basic (essentially neutral) compound (based on its pKa). 5'-Deoxy-5-fluorouridine is a metabolite of capecitabine. Within humans, 5'-deoxy-5-fluorouridine participates in a number of enzymatic reactions. In particular, 5'-deoxy-5-fluorouridine can be converted into fluorouracil and 5-deoxyribose-1-phosphate through the action of the enzyme thymidine phosphorylase. In addition, 5'-deoxy-5-fluorouridine and meprobamate can be biosynthesized from capecitabine through its interaction with the enzymes liver carboxylesterase 1 and cytidine deaminase. Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. In humans, 5'-deoxy-5-fluorouridine is involved in capecitabine action pathway. Capecitabine (Xeloda, Roche) is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. |
|---|
| Structure | C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(F)C(O)=NC1=O InChI=1S/C9H11FN2O5/c1-3-5(13)6(14)8(17-3)12-2-4(10)7(15)11-9(12)16/h2-3,5-6,8,13-14H,1H3,(H,11,15,16)/t3-,5-,6-,8-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-(beta-D-5-Desoxyribofuranoxyl)-5-fluoruracil | ChEBI | | 5'-DFUR | ChEBI | | 5'-DFUrd | ChEBI | | 5-Fluoro-5'-deoxyuridine | ChEBI | | Doxifluridina | ChEBI | | Doxifluridinum | ChEBI | | Furtulon | ChEBI | | Ro 21-9738 | ChEBI | | Ro 219738 | ChEBI | | Doxifluridine | Kegg | | 1-(b-D-5-Desoxyribofuranoxyl)-5-fluoruracil | Generator | | 1-(Β-D-5-desoxyribofuranoxyl)-5-fluoruracil | Generator | | 5'-Deoxy-5'-fluorouridine | HMDB | | 5'-Fluoro-5'-deoxyuridine | HMDB | | Doxyfluridine | HMDB | | 5'-Deoxy-5-fluorouridine | MeSH |
|
|---|
| Chemical Formula | C9H11FN2O5 |
|---|
| Average Molecular Weight | 246.1924 |
|---|
| Monoisotopic Molecular Weight | 246.065199677 |
|---|
| IUPAC Name | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-4-hydroxy-1,2-dihydropyrimidin-2-one |
|---|
| Traditional Name | doxifluridine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(F)C(O)=NC1=O |
|---|
| InChI Identifier | InChI=1S/C9H11FN2O5/c1-3-5(13)6(14)8(17-3)12-2-4(10)7(15)11-9(12)16/h2-3,5-6,8,13-14H,1H3,(H,11,15,16)/t3-,5-,6-,8-/m1/s1 |
|---|
| InChI Key | ZWAOHEXOSAUJHY-ZIYNGMLESA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 5'-deoxyribonucleosides. These are nucleosides in which the oxygen atom at the 5'position of the ribose moiety has been replaced by another atom. The nucleobases here are limited to purine, pyrimidine, and pyridine derivatives. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Nucleosides, nucleotides, and analogues |
|---|
| Class | 5'-deoxyribonucleosides |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | 5'-deoxyribonucleosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - 5'-deoxyribonucleoside
- Glycosyl compound
- N-glycosyl compound
- Halopyrimidine
- Pyrimidone
- Aryl fluoride
- Aryl halide
- Pyrimidine
- Hydropyrimidine
- Heteroaromatic compound
- Vinylogous amide
- Tetrahydrofuran
- Urea
- Secondary alcohol
- 1,2-diol
- Lactam
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organopnictogen compound
- Organohalogen compound
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Organic nitrogen compound
- Alcohol
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.27 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.3089 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.89 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 841.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 247.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 84.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 158.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 68.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 273.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 295.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 113.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 637.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 265.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 847.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 190.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 190.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 433.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 262.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 84.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 5'-Deoxy-5-fluorouridine,1TMS,isomer #1 | C[C@H]1O[C@@H](N2C=C(F)C(O)=NC2=O)[C@H](O[Si](C)(C)C)[C@@H]1O | 2098.9 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,1TMS,isomer #2 | C[C@H]1O[C@@H](N2C=C(F)C(O)=NC2=O)[C@H](O)[C@@H]1O[Si](C)(C)C | 2118.8 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,1TMS,isomer #3 | C[C@H]1O[C@@H](N2C=C(F)C(O[Si](C)(C)C)=NC2=O)[C@H](O)[C@@H]1O | 2063.0 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,2TMS,isomer #1 | C[C@H]1O[C@@H](N2C=C(F)C(O[Si](C)(C)C)=NC2=O)[C@H](O[Si](C)(C)C)[C@@H]1O | 2098.8 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,2TMS,isomer #2 | C[C@H]1O[C@@H](N2C=C(F)C(O)=NC2=O)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2119.8 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,2TMS,isomer #3 | C[C@H]1O[C@@H](N2C=C(F)C(O[Si](C)(C)C)=NC2=O)[C@H](O)[C@@H]1O[Si](C)(C)C | 2112.0 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,3TMS,isomer #1 | C[C@H]1O[C@@H](N2C=C(F)C(O[Si](C)(C)C)=NC2=O)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2151.1 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,1TBDMS,isomer #1 | C[C@H]1O[C@@H](N2C=C(F)C(O)=NC2=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 2352.9 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,1TBDMS,isomer #2 | C[C@H]1O[C@@H](N2C=C(F)C(O)=NC2=O)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 2371.5 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,1TBDMS,isomer #3 | C[C@H]1O[C@@H](N2C=C(F)C(O[Si](C)(C)C(C)(C)C)=NC2=O)[C@H](O)[C@@H]1O | 2298.0 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,2TBDMS,isomer #1 | C[C@H]1O[C@@H](N2C=C(F)C(O[Si](C)(C)C(C)(C)C)=NC2=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 2573.0 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,2TBDMS,isomer #2 | C[C@H]1O[C@@H](N2C=C(F)C(O)=NC2=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 2612.3 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,2TBDMS,isomer #3 | C[C@H]1O[C@@H](N2C=C(F)C(O[Si](C)(C)C(C)(C)C)=NC2=O)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 2583.5 | Semi standard non polar | 33892256 | | 5'-Deoxy-5-fluorouridine,3TBDMS,isomer #1 | C[C@H]1O[C@@H](N2C=C(F)C(O[Si](C)(C)C(C)(C)C)=NC2=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 2801.7 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 5'-Deoxy-5-fluorouridine GC-MS (Non-derivatized) - 70eV, Positive | splash10-056u-9210000000-68ddd4a6bcf1d8ff7c3f | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 5'-Deoxy-5-fluorouridine GC-MS (3 TMS) - 70eV, Positive | splash10-00tk-6976700000-d826a815dab6401bbc3d | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 5'-Deoxy-5-fluorouridine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 5'-Deoxy-5-fluorouridine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 10V, Positive-QTOF | splash10-001i-0910000000-7e78eab45706c44d825f | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 20V, Positive-QTOF | splash10-001i-1900000000-17e125f0d2b5d65e776e | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 40V, Positive-QTOF | splash10-03e9-9400000000-4647ffbb75476b52110a | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 10V, Negative-QTOF | splash10-004l-5950000000-62edf53c23a7fcae3dde | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 20V, Negative-QTOF | splash10-004i-4930000000-e1442f1a62dab8ca8e79 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 40V, Negative-QTOF | splash10-0006-9100000000-583eee0dde55403044a4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 10V, Positive-QTOF | splash10-0002-9810000000-af33e0acf393f434b2b4 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 20V, Positive-QTOF | splash10-001s-9800000000-ebb571742c6aab84653b | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 40V, Positive-QTOF | splash10-00ec-8900000000-11063d9f21aa7c8eb3df | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 10V, Negative-QTOF | splash10-004j-1890000000-1de9ab4256d6804b8f6a | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 20V, Negative-QTOF | splash10-0006-9600000000-64d7705d227c428a4b7c | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5'-Deoxy-5-fluorouridine 40V, Negative-QTOF | splash10-0006-9100000000-a2671dc87d34b4b003e3 | 2021-10-12 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|